263 related articles for article (PubMed ID: 29842991)
1. Key molecules in lymphatic development, function, and identification.
Jha SK; Rauniyar K; Jeltsch M
Ann Anat; 2018 Sep; 219():25-34. PubMed ID: 29842991
[TBL] [Abstract][Full Text] [Related]
2. [New insights into the molecular mechanisms of lymphangiogenesis and pathophysiology].
Hirakawa S
Yakugaku Zasshi; 2012; 132(2):211-4. PubMed ID: 22293702
[TBL] [Abstract][Full Text] [Related]
3. Lymphangiogenic growth factors, receptors and therapies.
Lohela M; Saaristo A; Veikkola T; Alitalo K
Thromb Haemost; 2003 Aug; 90(2):167-84. PubMed ID: 12888864
[TBL] [Abstract][Full Text] [Related]
4. COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction.
Yamazaki T; Yoshimatsu Y; Morishita Y; Miyazono K; Watabe T
Genes Cells; 2009 Mar; 14(3):425-34. PubMed ID: 19210544
[TBL] [Abstract][Full Text] [Related]
5. Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.
Shin JW; Min M; Larrieu-Lahargue F; Canron X; Kunstfeld R; Nguyen L; Henderson JE; Bikfalvi A; Detmar M; Hong YK
Mol Biol Cell; 2006 Feb; 17(2):576-84. PubMed ID: 16291864
[TBL] [Abstract][Full Text] [Related]
6. Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades.
Mishima K; Watabe T; Saito A; Yoshimatsu Y; Imaizumi N; Masui S; Hirashima M; Morisada T; Oike Y; Araie M; Niwa H; Kubo H; Suda T; Miyazono K
Mol Biol Cell; 2007 Apr; 18(4):1421-9. PubMed ID: 17287396
[TBL] [Abstract][Full Text] [Related]
7. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1.
Jha SK; Rauniyar K; Karpanen T; Leppänen VM; Brouillard P; Vikkula M; Alitalo K; Jeltsch M
Sci Rep; 2017 Jul; 7(1):4916. PubMed ID: 28687807
[TBL] [Abstract][Full Text] [Related]
8. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis.
Goldman J; Rutkowski JM; Shields JD; Pasquier MC; Cui Y; Schmökel HG; Willey S; Hicklin DJ; Pytowski B; Swartz MA
FASEB J; 2007 Apr; 21(4):1003-12. PubMed ID: 17210781
[TBL] [Abstract][Full Text] [Related]
9. CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.
Jeltsch M; Jha SK; Tvorogov D; Anisimov A; Leppänen VM; Holopainen T; Kivelä R; Ortega S; Kärpanen T; Alitalo K
Circulation; 2014 May; 129(19):1962-71. PubMed ID: 24552833
[TBL] [Abstract][Full Text] [Related]
10. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo.
Bos FL; Caunt M; Peterson-Maduro J; Planas-Paz L; Kowalski J; Karpanen T; van Impel A; Tong R; Ernst JA; Korving J; van Es JH; Lammert E; Duckers HJ; Schulte-Merker S
Circ Res; 2011 Aug; 109(5):486-91. PubMed ID: 21778431
[TBL] [Abstract][Full Text] [Related]
11. Changes in regulatory molecules for lymphangiogenesis in intestinal lymphangiectasia with enteric protein loss.
Hokari R; Kitagawa N; Watanabe C; Komoto S; Kurihara C; Okada Y; Kawaguchi A; Nagao S; Hibi T; Miura S
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e88-95. PubMed ID: 18005011
[TBL] [Abstract][Full Text] [Related]
12. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic endothelial regulation, lymphoedema, and lymph node metastasis.
Karkkainen MJ; Alitalo K
Semin Cell Dev Biol; 2002 Feb; 13(1):9-18. PubMed ID: 11969367
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.
Bui HM; Enis D; Robciuc MR; Nurmi HJ; Cohen J; Chen M; Yang Y; Dhillon V; Johnson K; Zhang H; Kirkpatrick R; Traxler E; Anisimov A; Alitalo K; Kahn ML
J Clin Invest; 2016 Jun; 126(6):2167-80. PubMed ID: 27159393
[TBL] [Abstract][Full Text] [Related]
15. Identification of targets of Prox1 during in vitro vascular differentiation from embryonic stem cells: functional roles of HoxD8 in lymphangiogenesis.
Harada K; Yamazaki T; Iwata C; Yoshimatsu Y; Sase H; Mishima K; Morishita Y; Hirashima M; Oike Y; Suda T; Miura N; Watabe T; Miyazono K
J Cell Sci; 2009 Nov; 122(Pt 21):3923-30. PubMed ID: 19825936
[TBL] [Abstract][Full Text] [Related]
16. Expression of platelet-derived growth factor receptor β is maintained by Prox1 in lymphatic endothelial cells and is required for tumor lymphangiogenesis.
Miyazaki H; Yoshimatsu Y; Akatsu Y; Mishima K; Fukayama M; Watabe T; Miyazono K
Cancer Sci; 2014 Sep; 105(9):1116-23. PubMed ID: 24981766
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of lymphangiogenesis.
Takahashi M; Yoshimoto T; Kubo H
Int J Hematol; 2004 Jul; 80(1):29-34. PubMed ID: 15293565
[TBL] [Abstract][Full Text] [Related]
18. DeepCAGE transcriptomics identify HOXD10 as a transcription factor regulating lymphatic endothelial responses to VEGF-C.
Klein S; Dieterich LC; Mathelier A; Chong C; Sliwa-Primorac A; Hong YK; Shin JW; Lizio M; Itoh M; Kawaji H; Lassmann T; Daub CO; Arner E; ; Carninci P; Hayashizaki Y; Forrest AR; Wasserman WW; Detmar M
J Cell Sci; 2016 Jul; 129(13):2573-85. PubMed ID: 27199372
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
Wilting J; Papoutsi M; Christ B; Nicolaides KH; von Kaisenberg CS; Borges J; Stark GB; Alitalo K; Tomarev SI; Niemeyer C; Rössler J
FASEB J; 2002 Aug; 16(10):1271-3. PubMed ID: 12060670
[TBL] [Abstract][Full Text] [Related]
20. Molecular control of lymphangiogenesis.
Baldwin ME; Stacker SA; Achen MG
Bioessays; 2002 Nov; 24(11):1030-40. PubMed ID: 12386934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]